Study Information
| Title: | Continued Safety Monitoring of Solanezumab in Alzheimer's Disease  |
| Status: | Recruiting participants |
| Conditions: | Alzheimer's Disease |
| Interventions: | Drug: Solanezumab |
| Health Topics: | Alzheimer's Disease |
Contact Information
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Belmont, MA 02478
Eli Lilly